共 50 条
- [3] Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT [J]. ESC HEART FAILURE, 2021, 8 (05): : 3875 - 3884
- [4] Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 146 - 150
- [8] Efficacy of Tafamidis in Patients with Hereditary or Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Results from the ATTR-ACT Trial [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S204 - S204